Sharlene L Leurig
Examiner (ID: 11491)
Most Active Art Unit | 2879 |
Art Unit(s) | 2879 |
Total Applications | 146 |
Issued Applications | 124 |
Pending Applications | 2 |
Abandoned Applications | 20 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 8779637
[patent_doc_number] => 20130101612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-25
[patent_title] => 'VACCINE FOR ENVELOPED VIRUSES'
[patent_app_type] => utility
[patent_app_number] => 13/459184
[patent_app_country] => US
[patent_app_date] => 2012-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5297
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13459184
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/459184 | Vaccine for enveloped viruses | Apr 28, 2012 | Issued |
Array
(
[id] => 9413048
[patent_doc_number] => 08697084
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-15
[patent_title] => 'HIV consensus envelope sequences and methods for using the same'
[patent_app_type] => utility
[patent_app_number] => 13/458013
[patent_app_country] => US
[patent_app_date] => 2012-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 92
[patent_no_of_words] => 35726
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13458013
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/458013 | HIV consensus envelope sequences and methods for using the same | Apr 26, 2012 | Issued |
Array
(
[id] => 13127475
[patent_doc_number] => 10081658
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-25
[patent_title] => Truncated HIV envelope proteins (ENV), methods and compositions related thereto
[patent_app_type] => utility
[patent_app_number] => 14/113094
[patent_app_country] => US
[patent_app_date] => 2012-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 87
[patent_figures_cnt] => 63
[patent_no_of_words] => 35189
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14113094
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/113094 | Truncated HIV envelope proteins (ENV), methods and compositions related thereto | Apr 24, 2012 | Issued |
Array
(
[id] => 8382199
[patent_doc_number] => 20120225823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-06
[patent_title] => 'Allosteric Modulation of the Dopamine Transporter Protein for the Treatment of HIV-1 Induced Neurologic Dysfunction'
[patent_app_type] => utility
[patent_app_number] => 13/454209
[patent_app_country] => US
[patent_app_date] => 2012-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11458
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13454209
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/454209 | Allosteric Modulation of the Dopamine Transporter Protein for the Treatment of HIV-1 Induced Neurologic Dysfunction | Apr 23, 2012 | Abandoned |
Array
(
[id] => 9771865
[patent_doc_number] => 20140295528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'NOVELPOLYPEPTIDES AND BACTERIOPHAGES SPECIFIC TO KLEBSIELLA PNEUMONIAE CAPSULAR TYPE STRAINS'
[patent_app_type] => utility
[patent_app_number] => 14/112870
[patent_app_country] => US
[patent_app_date] => 2012-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 61758
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14112870
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/112870 | Polypeptides and bacteriophages specific to Klebsiella pneumoniae capsular type strains | Apr 19, 2012 | Issued |
Array
(
[id] => 8358652
[patent_doc_number] => 20120213811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-23
[patent_title] => 'CHIMERIC HIV FUSION PROTEINS AS VACCINES'
[patent_app_type] => utility
[patent_app_number] => 13/452358
[patent_app_country] => US
[patent_app_date] => 2012-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11279
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13452358
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/452358 | Chimeric HIV fusion proteins as vaccines | Apr 19, 2012 | Issued |
Array
(
[id] => 17163165
[patent_doc_number] => 11149254
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-19
[patent_title] => Clonal strains of attenuated vaccinia viruses and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 13/506369
[patent_app_country] => US
[patent_app_date] => 2012-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 116568
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13506369
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/506369 | Clonal strains of attenuated vaccinia viruses and methods of use thereof | Apr 12, 2012 | Issued |
Array
(
[id] => 8323511
[patent_doc_number] => 20120195927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-02
[patent_title] => 'GM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS'
[patent_app_type] => utility
[patent_app_number] => 13/446558
[patent_app_country] => US
[patent_app_date] => 2012-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13312
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13446558
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/446558 | gM-negative EHV-mutants without heterologous elements | Apr 12, 2012 | Issued |
Array
(
[id] => 9094324
[patent_doc_number] => 20130273635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-17
[patent_title] => 'BACTERIOPHAGE KILLING PSEUDOMONAS AERUGINOSA AND STAPHYLOCOCCUS AUREUS'
[patent_app_type] => utility
[patent_app_number] => 13/445564
[patent_app_country] => US
[patent_app_date] => 2012-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4829
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13445564
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/445564 | BACTERIOPHAGE KILLING PSEUDOMONAS AERUGINOSA AND STAPHYLOCOCCUS AUREUS | Apr 11, 2012 | Abandoned |
Array
(
[id] => 8685022
[patent_doc_number] => 20130053306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-28
[patent_title] => 'USE OF HISTONES FOR THE EARLY DIAGNOSIS AND/OR PREVENTIVE THERAPY OF VIRALLY-INFECTED LIVING CELLS AND A BIOCHIP FOR CARRYING OUT SAID DIAGNOSIS'
[patent_app_type] => utility
[patent_app_number] => 13/436788
[patent_app_country] => US
[patent_app_date] => 2012-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3122
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13436788
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/436788 | USE OF HISTONES FOR THE EARLY DIAGNOSIS AND/OR PREVENTIVE THERAPY OF VIRALLY-INFECTED LIVING CELLS AND A BIOCHIP FOR CARRYING OUT SAID DIAGNOSIS | Mar 29, 2012 | Abandoned |
Array
(
[id] => 9280337
[patent_doc_number] => 20140030306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-30
[patent_title] => 'METHODS AND COMPOSITIONS FOR REMEDIATING MICROBIAL INDUCED CORROSION AND ENVIRONMENTAL DAMAGE, AND FOR IMPROVING WASTEWATER TREATMENT PROCESSES'
[patent_app_type] => utility
[patent_app_number] => 14/008942
[patent_app_country] => US
[patent_app_date] => 2012-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 24694
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008942
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/008942 | METHODS AND COMPOSITIONS FOR REMEDIATING MICROBIAL INDUCED CORROSION AND ENVIRONMENTAL DAMAGE, AND FOR IMPROVING WASTEWATER TREATMENT PROCESSES | Mar 28, 2012 | Abandoned |
Array
(
[id] => 10587895
[patent_doc_number] => 09309498
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-12
[patent_title] => 'Bacteriophage having bactericidal activity with respect to Actinobacillus pleuropneumoniae'
[patent_app_type] => utility
[patent_app_number] => 14/349899
[patent_app_country] => US
[patent_app_date] => 2012-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2235
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14349899
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/349899 | Bacteriophage having bactericidal activity with respect to Actinobacillus pleuropneumoniae | Mar 21, 2012 | Issued |
Array
(
[id] => 8289277
[patent_doc_number] => 20120177609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-12
[patent_title] => 'METHOD FOR USING LIBERATED DORMANT BACTERIOPHASE AND ENVIRONMENTAL STRESS TO REDUCE INFECTIOUS BACTERIA'
[patent_app_type] => utility
[patent_app_number] => 13/425555
[patent_app_country] => US
[patent_app_date] => 2012-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4548
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13425555
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/425555 | METHOD FOR USING LIBERATED DORMANT BACTERIOPHASE AND ENVIRONMENTAL STRESS TO REDUCE INFECTIOUS BACTERIA | Mar 20, 2012 | Abandoned |
Array
(
[id] => 9232355
[patent_doc_number] => 08597657
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-03
[patent_title] => 'Mutated env sequence involved in the modulation of the immunosuppressive effect of viral proteins'
[patent_app_type] => utility
[patent_app_number] => 13/399208
[patent_app_country] => US
[patent_app_date] => 2012-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 38
[patent_no_of_words] => 24188
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13399208
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/399208 | Mutated env sequence involved in the modulation of the immunosuppressive effect of viral proteins | Feb 16, 2012 | Issued |
Array
(
[id] => 8452807
[patent_doc_number] => 20120263754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-18
[patent_title] => 'Methods for Enhancing Immunogen Specific Immune Responses by Vectored Vaccines'
[patent_app_type] => utility
[patent_app_number] => 13/397216
[patent_app_country] => US
[patent_app_date] => 2012-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 35397
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13397216
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/397216 | Methods for Enhancing Immunogen Specific Immune Responses by Vectored Vaccines | Feb 14, 2012 | Abandoned |
Array
(
[id] => 10869835
[patent_doc_number] => 08895027
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-25
[patent_title] => 'Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene'
[patent_app_type] => utility
[patent_app_number] => 13/364993
[patent_app_country] => US
[patent_app_date] => 2012-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 56
[patent_figures_cnt] => 58
[patent_no_of_words] => 19317
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13364993
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/364993 | Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene | Feb 1, 2012 | Issued |
Array
(
[id] => 8138455
[patent_doc_number] => 20120093777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-19
[patent_title] => 'COMPOSITIONS COMPRISING VIRUSES AND METHODS FOR CONCENTRATING VIRUS PREPARATIONS'
[patent_app_type] => utility
[patent_app_number] => 13/334403
[patent_app_country] => US
[patent_app_date] => 2011-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8013
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20120093777.pdf
[firstpage_image] =>[orig_patent_app_number] => 13334403
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/334403 | COMPOSITIONS COMPRISING VIRUSES AND METHODS FOR CONCENTRATING VIRUS PREPARATIONS | Dec 21, 2011 | Abandoned |
Array
(
[id] => 9232626
[patent_doc_number] => 08597928
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-03
[patent_title] => 'Bacteriophage of the siphoviridae family and antibacterial compositions comprising the same'
[patent_app_type] => utility
[patent_app_number] => 13/331639
[patent_app_country] => US
[patent_app_date] => 2011-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 11558
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13331639
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/331639 | Bacteriophage of the siphoviridae family and antibacterial compositions comprising the same | Dec 19, 2011 | Issued |
Array
(
[id] => 10966966
[patent_doc_number] => 20140369998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-18
[patent_title] => 'Biomarkers for Tuberculosis and HIV/AIDS'
[patent_app_type] => utility
[patent_app_number] => 13/992458
[patent_app_country] => US
[patent_app_date] => 2011-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 8658
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13992458
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/992458 | Biomarkers for Tuberculosis and HIV/AIDS | Dec 8, 2011 | Abandoned |
Array
(
[id] => 9205327
[patent_doc_number] => 20140004504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE DETECTION AND ANALYSIS OF AFRICAN SWINE FEVER VIRUS'
[patent_app_type] => utility
[patent_app_number] => 13/993028
[patent_app_country] => US
[patent_app_date] => 2011-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11242
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13993028
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/993028 | COMPOSITIONS AND METHODS FOR THE DETECTION AND ANALYSIS OF AFRICAN SWINE FEVER VIRUS | Dec 8, 2011 | Abandoned |